Cumulative Confirmed Cases in Gyeongbuk Province Reach 1,554 as of Midnight on the 12th

An interim result announced that the COVID-19 vaccine jointly developed by the American pharmaceutical company Pfizer and the German BioNTech has an efficacy of over 90%. The photo shows the Korea Pfizer Pharmaceutical office in Jung-gu, Seoul, on the afternoon of November 10. [Image source=Yonhap News] Photo by Yonhap News

An interim result announced that the COVID-19 vaccine jointly developed by the American pharmaceutical company Pfizer and the German BioNTech has an efficacy of over 90%. The photo shows the Korea Pfizer Pharmaceutical office in Jung-gu, Seoul, on the afternoon of November 10. [Image source=Yonhap News] Photo by Yonhap News

View original image

[Asia Economy Yeongnam Reporting Headquarters, Reporter Park Dong-wook] One more confirmed case of the novel coronavirus infection (COVID-19) has been reported in Gyeongsan-si, Gyeongbuk.


According to Gyeongbuk Province on the 12th, as of midnight, the number of confirmed COVID-19 cases in the region increased by one from the previous day, totaling 1,554. The cumulative confirmed cases in Gyeongsan-si rose to 669.


A woman in her 60s living in Gyeongsan was classified as a contact of a confirmed case in Daegu and tested positive on the 11th. It was confirmed that on the 3rd, she had a meal with six acquaintances and a confirmed case from Osolgilda Bang in Dong-gu, Daegu. Except for this woman, the others tested negative.



The occurrence of community infection confirmed cases in Gyeongbuk Province on this day is the first in four days.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing